RankAlpha logo
Back to Rankings

SRPT

Sarepta TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SRPT vs peer average
23/100
SRPT vs. peer average (D vs. B)
Grade spread
B 7 · C 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

Gilead — larger antiviral/biotech with recent gene-therapy investments; serves as a commercial-scale comparator for later-stage launches and supply-chain execution.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
SRPT
Sarepta Therapeutics
GILD
Gilead Sciences
Grade
D
C
Momentum
4
35
Value
41
64
Sentiment
100
61
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs GILD

SRPT / GILD
Grade Position
Below peers
SRPT vs. peer average (D vs. B)
23/100
Momentum
4
GILD
Value
41
GILD
Sentiment
100
SRPT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SRPT
1
GILD
GILD
C
60/100
-1
2
RARE
RARE
C
60/100
-1
3
VRTX
VRTX
B
80/100
-2
4
NUVB
Nuvation Bio Inc Class A Common
B
80/100
-2
5
AAPG
Ascentage Pharma Group International ADR Unsp
N/A
-
-
GILD is the first peer returned for this comparison set.